|
注册号: Registration number: |
ChiCTR1800016054 |
|
最近更新日期: Date of Last Refreshed on: |
2018-05-08 22:26:39 |
|
注册时间: Date of Registration: |
2018-05-08 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
全国多中心孕期人群常见单基因病携带者筛查 |
|
Public title: |
Expanded carrier screening of monogenic diseases in couples during pregnancy: A prospective multi-center study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
全国多中心单基因病携带者早孕期筛查效率和认知度研究 |
|
Scientific title: |
Expanded carrier screening of monogenic diseases in couples during pregnancy: A prospective multi-center study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
向嘉乐 |
研究负责人: |
刘俊涛 |
|
Applicant: |
Jiale Xiang |
Study leader: |
Juntao LIU |
|
申请注册联系人电话: Applicant telephone: |
+86 0755-36307011 |
研究负责人电话:
Study leader's |
+86 010-69155648 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
xiangjiale@bgi.com |
研究负责人电子邮件: Study leader's E-mail: |
liujt@pumch.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
深圳市盐田区洪安三街21号华大综合园7栋 |
研究负责人通讯地址: |
北京市东城区帅府园一号 |
|
Applicant address: |
7th Building, Huada Garden, 21 Third Hong'an Street, Yantian, Shenzhen, China |
Study leader's address: |
1 Shuaifuyuan, Wangfujing Street, Dongcheng, District, Beijing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
深圳华大基因股份有限公司 |
||
|
Applicant's institution: |
BGI Genomics Inc. |
||
|
研究负责人所在单位: |
北京协和医院 |
||
|
Affiliation of the Leader: |
Peking Union Medical College Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
HS-1572 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京协和医院伦理委员会 |
||
|
Name of the ethic committee: |
Institutional Review Boards of Peking Union Medical College Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2018-04-24 00:00:00 | ||
|
伦理委员会联系人: |
徐辉 |
||
|
Contact Name of the ethic committee: |
Hui Xu |
||
|
伦理委员会联系地址: |
北京市东城区帅府园一号 |
||
|
Contact Address of the ethic committee: |
1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
北京协和医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Peking Union Medical College Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市东城区帅府园一号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
1 Shuaifuyuan, Wangfujing Street, Dongcheng, District, Beijing, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
深圳华大基因股份有限公司 |
||||||||||||||||||||||
|
Source(s) of funding: |
BGI Genomics Inc. |
||||||||||||||||||||||
|
研究疾病: |
单基因遗传病 |
||||||||||||||||||||||
|
Target disease: |
monogenic diseases |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
筛查 |
||||||||||||||||||||||
|
Study type: |
Screening |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
探索中国常见的单基因遗传疾病的携带率和不同地区的携带差异,评估中国人群中常见单基因病的频率谱,确定适合中国人的单基因病携带者筛查panel. |
||||||||||||||||||||||
|
Objectives of Study: |
To investigate the carrier status of monogenic diseases in China, and then design a proper screening panel for Chinese population. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1)不符合入组标准者 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Individuals with consanguineous marriage; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2018-05-01 00:00:00至 To 2019-11-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2018-05-01 00:00:00 至 To 2018-10-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
N/A |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
N/A |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2019-12-30 文章发表及邮箱询问 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
2019-12-30 study publish and requested by email |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
医院专人负责招募志愿者。项目过程中,数据信息表由各医院自行保存,项目结束后统一归档至北京协和医院。电子采集和管理系统用于信息数据管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Persons in hospital are responsible for recruitment. The case record forms are documented in different centers during the implementation of this study, and delivery to Peking Union Medical College Hospital for final documentation. Electronic Data Capture is used for data management. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |